Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance.
Saved in:
| Title: | Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance. |
|---|---|
| Authors: | Schröder M; Novartis Institutes for BioMedical Research, Basel, Switzerland. martin-1.schroeder@novartis.com., Renatus M; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland., Liang X; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Meili F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Zoller T; Novartis Institutes for BioMedical Research, Basel, Switzerland., Ferrand S; Novartis Institutes for BioMedical Research, Basel, Switzerland., Gauter F; Novartis Institutes for BioMedical Research, Basel, Switzerland., Li X; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Sigoillot F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Gleim S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Stachyra TM; Novartis Institutes for BioMedical Research, Basel, Switzerland., Thomas JR; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Begue D; Novartis Institutes for BioMedical Research, Basel, Switzerland., Khoshouei M; Novartis Institutes for BioMedical Research, Basel, Switzerland., Lefeuvre P; Novartis Institutes for BioMedical Research, Basel, Switzerland., Andraos-Rey R; Novartis Institutes for BioMedical Research, Basel, Switzerland., Chung B; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Ma R; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Pinch B; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Hofmann A; Novartis Institutes for BioMedical Research, Basel, Switzerland., Schirle M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Schmiedeberg N; Novartis Institutes for BioMedical Research, Basel, Switzerland., Imbach P; Novartis Institutes for BioMedical Research, Basel, Switzerland., Gorses D; Novartis Institutes for BioMedical Research, Basel, Switzerland., Calkins K; Novartis Institutes for BioMedical Research, Basel, Switzerland., Bauer-Probst B; Novartis Institutes for BioMedical Research, Basel, Switzerland., Maschlej M; Novartis Institutes for BioMedical Research, Basel, Switzerland., Niederst M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Maher R; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Henault M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Alford J; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Ahrne E; Novartis Institutes for BioMedical Research, Basel, Switzerland., Tordella L; Novartis Institutes for BioMedical Research, Basel, Switzerland., Hollingworth G; Novartis Institutes for BioMedical Research, Basel, Switzerland., Thomä NH; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Swiss Institute for Experimental Cancer Research (ISREC), École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Vulpetti A; Novartis Institutes for BioMedical Research, Basel, Switzerland., Radimerski T; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland., Holzer P; Novartis Institutes for BioMedical Research, Basel, Switzerland., Carbonneau S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Thoma CR; Novartis Institutes for BioMedical Research, Cambridge, MA, USA. cthoma@ridgelinediscovery.com.; Ridgeline Discovery, Basel, Switzerland. cthoma@ridgelinediscovery.com. |
| Source: | Nature communications [Nat Commun] 2024 Aug 19; Vol. 15 (1), pp. 7109. Date of Electronic Publication: 2024 Aug 19. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39160182 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schröder+M%22">Schröder M</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland. martin-1.schroeder@novartis.com.<br /><searchLink fieldCode="AU" term="%22Renatus+M%22">Renatus M</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Liang+X%22">Liang X</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Meili+F%22">Meili F</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zoller+T%22">Zoller T</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ferrand+S%22">Ferrand S</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gauter+F%22">Gauter F</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sigoillot+F%22">Sigoillot F</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gleim+S%22">Gleim S</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Stachyra+TM%22">Stachyra TM</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Thomas+JR%22">Thomas JR</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Begue+D%22">Begue D</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Khoshouei+M%22">Khoshouei M</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lefeuvre+P%22">Lefeuvre P</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Andraos-Rey+R%22">Andraos-Rey R</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Chung+B%22">Chung B</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ma+R%22">Ma R</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pinch+B%22">Pinch B</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hofmann+A%22">Hofmann A</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schirle+M%22">Schirle M</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Schmiedeberg+N%22">Schmiedeberg N</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Imbach+P%22">Imbach P</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gorses+D%22">Gorses D</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Calkins+K%22">Calkins K</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bauer-Probst+B%22">Bauer-Probst B</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Maschlej+M%22">Maschlej M</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Niederst+M%22">Niederst M</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Maher+R%22">Maher R</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Henault+M%22">Henault M</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Alford+J%22">Alford J</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ahrne+E%22">Ahrne E</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tordella+L%22">Tordella L</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hollingworth+G%22">Hollingworth G</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Thomä+NH%22">Thomä NH</searchLink>; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Swiss Institute for Experimental Cancer Research (ISREC), École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Vulpetti+A%22">Vulpetti A</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Radimerski+T%22">Radimerski T</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Holzer+P%22">Holzer P</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Carbonneau+S%22">Carbonneau S</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Thoma+CR%22">Thoma CR</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA. cthoma@ridgelinediscovery.com.; Ridgeline Discovery, Basel, Switzerland. cthoma@ridgelinediscovery.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Aug 19; Vol. 15 (1), pp. 7109. <i>Date of Electronic Publication: </i>2024 Aug 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39160182 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-024-51317-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 7109 Titles: – TitleFull: Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schröder M – PersonEntity: Name: NameFull: Renatus M – PersonEntity: Name: NameFull: Liang X – PersonEntity: Name: NameFull: Meili F – PersonEntity: Name: NameFull: Zoller T – PersonEntity: Name: NameFull: Ferrand S – PersonEntity: Name: NameFull: Gauter F – PersonEntity: Name: NameFull: Li X – PersonEntity: Name: NameFull: Sigoillot F – PersonEntity: Name: NameFull: Gleim S – PersonEntity: Name: NameFull: Stachyra TM – PersonEntity: Name: NameFull: Thomas JR – PersonEntity: Name: NameFull: Begue D – PersonEntity: Name: NameFull: Khoshouei M – PersonEntity: Name: NameFull: Lefeuvre P – PersonEntity: Name: NameFull: Andraos-Rey R – PersonEntity: Name: NameFull: Chung B – PersonEntity: Name: NameFull: Ma R – PersonEntity: Name: NameFull: Pinch B – PersonEntity: Name: NameFull: Hofmann A – PersonEntity: Name: NameFull: Schirle M – PersonEntity: Name: NameFull: Schmiedeberg N – PersonEntity: Name: NameFull: Imbach P – PersonEntity: Name: NameFull: Gorses D – PersonEntity: Name: NameFull: Calkins K – PersonEntity: Name: NameFull: Bauer-Probst B – PersonEntity: Name: NameFull: Maschlej M – PersonEntity: Name: NameFull: Niederst M – PersonEntity: Name: NameFull: Maher R – PersonEntity: Name: NameFull: Henault M – PersonEntity: Name: NameFull: Alford J – PersonEntity: Name: NameFull: Ahrne E – PersonEntity: Name: NameFull: Tordella L – PersonEntity: Name: NameFull: Hollingworth G – PersonEntity: Name: NameFull: Thomä NH – PersonEntity: Name: NameFull: Vulpetti A – PersonEntity: Name: NameFull: Radimerski T – PersonEntity: Name: NameFull: Holzer P – PersonEntity: Name: NameFull: Carbonneau S – PersonEntity: Name: NameFull: Thoma CR IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 08 Text: 2024 Aug 19 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |